• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Bayer`s asundexian failed to prevent strokes, imperiling $5.5B blockbuster hopes

    FIERCE BIOTECH

    Bayer Receives U.S. FDA Fast Track Designation for asundexian

    BUSINESSWIRE

    Bayer kicks off Phase III studies of oral factor XIa inhibitor asundexian

    BUSINESSWIRE

    Bayer Initiates PIII Study for Investigational Oral FXIa Inhibitor Asundexian

    BUSINESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.